Cargando…
Baicalin alleviates benign prostate hyperplasia through androgen-dependent apoptosis
BPH is a disease prevalent among elderly men that is characterized by abnormal proliferation of prostatic epithelial and stromal tissues. No effective treatment exists for BPH owing to lack of a clear understanding of its molecular etiology. Although several studies have reported therapeutic effects...
Autores principales: | Jin, Bo-Ram, An, Hyo-Jin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7041748/ https://www.ncbi.nlm.nih.gov/pubmed/32018227 http://dx.doi.org/10.18632/aging.102731 |
Ejemplares similares
-
Antioxidant mitoquinone suppresses benign prostatic hyperplasia by regulating the AR–NLRP3 pathway
por: Jin, Bo-Ram, et al.
Publicado: (2023) -
Oral administration of berberine represses macrophage activation-associated benign prostatic hyperplasia: a pivotal involvement of the NF-κB
por: Jin, Bo-Ram, et al.
Publicado: (2021) -
Anti-Proliferative Effects of HBX-5 on Progression of Benign Prostatic Hyperplasia
por: Jin, Bo-Ram, et al.
Publicado: (2018) -
Eriochloa villosa Alleviates Progression of Benign Prostatic Hyperplasia in vitro and in vivo
por: Baek, Eun Bok, et al.
Publicado: (2022) -
Androgen receptor isoforms expression in benign prostatic hyperplasia and primary prostate cancer
por: Hillebrand, Ana Caroline, et al.
Publicado: (2018)